Breadcrumb Home Studies Studies Search Filter Research Area AllComplications & ComorbiditiesCureTreatmentTuberculosis Study Status AllClosed to AccrualClosed to Follow UpConcludedEnrollingIn DevelopmentParticipants Off Study and Primary Analysis CompletedPending Sort Study Number AscStudy Number Desc Submit Search Showing 11 studies. IMPAACT 2046: UPLIFT Study DAIDS Number TBA Research Area Brain and Mental Health Study Status In Development P1112: Monoclonal Antibody PK Study DAIDS Number 11903 Research Area Therapeutics Study Status Participants Off Study and Primary Analysis Completed P1101: Phase I/II Dose-Finding, Safety, Tolerance and Pharmacokinetics Study of a Raltegravir-Containing Antiretroviral Therapy (ART) Regimen in HIV-infected and TB Co-infected Infants and Children DAIDS Number 11831 Research Area Treatment Study Status Concluded P1094: Evaluation of the use 3TC DAIDS Number 11769 Research Area Other Study Status Concluded P1078: TB APPRISE: TB Ante vs. Postpartum Prevention with INH in HIV Seropositive mothers and their Exposed infants DAIDS Number 10732 Research Area Tuberculosis P1045: Prevalence of Metabolic Abnormalities in Vertically HIV-infected Children DAIDS Number 10108 Research Area Other Study Status Concluded P1038: Safety of High Dose Lopinavir/Ritonavir with and without Saquinavir DAIDS Number 10045 Research Area Other Study Status Concluded P1020A: A Phase I/II, Open-Label, Pharmacokinetic and Safety Study of a Novel Protease Inhibitor (BMS-232632, Atazanavir, ATV, Reyataz) in Combination Regimens in Antiretroviral Therapy (ART)-Naive and Experienced HIV-infected Infants, Children and Adolescents DAIDS Number 10037 Research Area Treatment Study Status Concluded P1010: Effect of Antiretroviral Therapy on Body Composition in Children. DAIDS Number 10814 Research Area Other Study Status Concluded P1007: Phase I Salvage Therapy DAIDS Number 10315 Research Area Other Study Status Concluded Pagination Current page 1 Page 2 Next page Next
IMPAACT 2046: UPLIFT Study DAIDS Number TBA Research Area Brain and Mental Health Study Status In Development
P1112: Monoclonal Antibody PK Study DAIDS Number 11903 Research Area Therapeutics Study Status Participants Off Study and Primary Analysis Completed
P1101: Phase I/II Dose-Finding, Safety, Tolerance and Pharmacokinetics Study of a Raltegravir-Containing Antiretroviral Therapy (ART) Regimen in HIV-infected and TB Co-infected Infants and Children DAIDS Number 11831 Research Area Treatment Study Status Concluded
P1078: TB APPRISE: TB Ante vs. Postpartum Prevention with INH in HIV Seropositive mothers and their Exposed infants DAIDS Number 10732 Research Area Tuberculosis
P1045: Prevalence of Metabolic Abnormalities in Vertically HIV-infected Children DAIDS Number 10108 Research Area Other Study Status Concluded
P1038: Safety of High Dose Lopinavir/Ritonavir with and without Saquinavir DAIDS Number 10045 Research Area Other Study Status Concluded
P1020A: A Phase I/II, Open-Label, Pharmacokinetic and Safety Study of a Novel Protease Inhibitor (BMS-232632, Atazanavir, ATV, Reyataz) in Combination Regimens in Antiretroviral Therapy (ART)-Naive and Experienced HIV-infected Infants, Children and Adolescents DAIDS Number 10037 Research Area Treatment Study Status Concluded
P1010: Effect of Antiretroviral Therapy on Body Composition in Children. DAIDS Number 10814 Research Area Other Study Status Concluded
